Product information

From Health Canada

Current status:

Dormant

Current status date:

2015-05-25

Original market date: See footnote 1

1984-12-31

Product name:

POTASSIUM ACETATE INJECTION

Description:

SINGLE-DOSE VIAL

DIN:

02139553 Electronic product monograph is not available

Company:

FRESENIUS KABI CANADA LTD
165 Galaxy Blvd, Suite 100
Toronto
Ontario
Canada M9W 0C8

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Intravenous

Number of active ingredient(s):

1

Schedule(s):

Ethical

 

American Hospital Formulary Service (AHFS): See footnote 3

40:12.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

B05XA17 POTASSIUM ACETATE

Active ingredient group (AIG) number:See footnote5

0107304002

List of active ingredient(s)
Active ingredient(s) Strength
POTASSIUM ACETATE 392 MG / ML
Version 4.0.2
Date modified: